mitomycin has been researched along with thiotepa in 115 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 73 (63.48) | 18.7374 |
1990's | 30 (26.09) | 18.2507 |
2000's | 7 (6.09) | 29.6817 |
2010's | 5 (4.35) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hansch, C; Khwaja, TA; Selassie, CD | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ma, GJ; Wang, S; Wang, YP; Xue, KX | 1 |
Wang, SH | 1 |
Droller, MJ; Flanigan, RC; Nseyo, UO; Soloway, MS | 1 |
Soloway, MS | 6 |
Bonichon, F; Chauvergne, J; Dilhuydy, JM; Durand, M; Mauriac, L | 1 |
Cho, YH; Smith, JA; Straight, RC | 1 |
Bilbao, JI; Longo, JM; Mansilla, F; Muñoz-Galindo, L; Rebollo, J; Vieitez, JM | 1 |
Chauffert, B; Dimanche-Boitrel, MT; Genne, P; Jeannin, JF; Onier, N; Petit, JM | 1 |
Richie, JP | 1 |
Crawford, ED; Thrasher, JB | 1 |
Brosman, SA | 1 |
Akaza, H; Koiso, K; Miyanaga, N | 1 |
Gelmann, EP; Lynch, JH; Sommers, CL; Tarkington, M; Tefft, MC | 1 |
Foo, KT; Tan, EC; Tock, EP; Tung, KH | 1 |
Kajikawa, F; Kashimoto, S; Nakamura, S; Nakata, K | 1 |
Huben, RP; Perrapato, SD; Rustum, YM; Seraphim, LA; Slocum, HK | 1 |
Friedman, D; Kim, H; Mooppan, UM; Rosen, Y | 1 |
Avril, A; Dilhuydy, JM; Durand, M; Mauriac, L | 1 |
Callery, PS; Musser, SM | 1 |
Andrieu, JM; De Luca, JC; Dulout, FN; Furnus, CC; Ulrich, MA | 1 |
Chang, SY; Ma, CP; Wang, J; Yu, DS | 1 |
King, M; Trybula, M | 1 |
Torti, FM | 1 |
Bahnson, R; Ratliff, TL | 1 |
Griffin, BR; Griffin, TW; Koh, WJ; Markette, KL; Russell, AH; Russell, KJ; Tong, DY | 1 |
Droller, MJ; Irwin, R; Prout, GR; Soloway, MS; Zincke, H | 1 |
Freedman, LS; Hargreave, TB; Parmar, MK; Tolley, DA | 1 |
deKernion, JB; Mukamel, E | 1 |
Callery, PS; Musser, SM; Pan, SS | 1 |
Jordan, AM; Murphy, WM; Soloway, MS | 1 |
Adelstein, EH; Barrett, BA; Ross, G; Weaver, DJ | 1 |
Culp, DA; Loening, SA; Mobley, WC; Narayana, AS | 1 |
Chauvergne, J; David, M; Durand, M; Hoerni, B; Mauriac, L | 1 |
Butler, KM; Ellison, MF; Flanigan, RC; Gomella, LG; McRoberts, JW | 1 |
Groos, E; Masters, JR | 1 |
Groos, E; Masters, JR; Walker, L | 1 |
English, PJ; Hepburn, PJ; Masters, JR; Parris, CN; Walker, MC | 1 |
Levin, DR; Moskovitz, B | 1 |
English, P; Masters, JR; Newman, B; Parris, CN; Riddle, P; Walker, MC | 1 |
Perry, A; Soloway, MS | 1 |
Elhilali, M; Konowalchuk, TW; Mackillop, WJ | 1 |
Aoyama, H; Hashimoto, M; Hiramatsu, T; Hirao, Y; Ohara, S; Okajima, E; Ozono, S; Watanabe, S; Yamada, K; Yoshida, K | 1 |
Alter, AJ; Malek, GH | 1 |
Inui, N; Kitajima, H; Konishi, S; Sato, S; Takizawa, H | 1 |
Heney, NM | 1 |
Hardeman, SW; Perry, A; Soloway, MS | 1 |
Barton, B; Hazra, T; Heney, NM; Koontz, WW; Soloway, M; Trump, DL; Weinstein, RS | 1 |
Gonder, M; Hu, KN; Khan, AS; Kim, A; Soroff, H | 1 |
Smith, PH | 2 |
Benson, RC; Hilton, JF; Taylor, WF; Zincke, H | 1 |
Droller, MJ; Walsh, PC | 1 |
Whitmore, WF | 1 |
Lalude, AO; Miller, JB; Weisenthal, LM | 1 |
Spaulding, JT | 1 |
Uchibayashi, T | 1 |
Ohmori, H | 1 |
Paulson, DF | 1 |
Lum, BL | 1 |
Murphy, WM | 1 |
Fujii, T; Nakatsuka, T | 1 |
Friedell, GH | 1 |
Catalona, WJ; Oakley, DM; Ratliff, TL; Shapiro, A | 1 |
Chebotarev, AN; Shcheglova, EG | 1 |
Block, NL; Brannen, G; Cummings, KB; Flanagan, M; Issell, BF; Levin, EA; Prout, GR; Soloway, MS; Summers, JL; Veenema, R | 1 |
Koontz, WW | 1 |
Lum, BL; Torti, FM | 1 |
Prout, GR | 1 |
Kopp, J; Prout, GR | 1 |
Colyer, SP; DuFrain, RJ; Littlefield, LG; Sayer, AM | 1 |
Flynn, C; Ramsden, C; Whelan, P | 1 |
Belpomme, D; Boiron, M; Gisselbrecht, C; Marty, M; Mathé, G; Mignot, L | 1 |
McCallum, LW; Murphy, WM; Nissenkorn, I; Soloway, MS | 1 |
Brunet, R; Bui, BN; Chauvergne, J; Durand, M; Hoerni, B; Mauriac, L | 1 |
Daly, JJ; DeFuria, MD; Griffin, PP; Nocks, BN; Prout, GR | 1 |
Hofmann, W; Langkopf, B | 1 |
Lamm, DL | 1 |
al-Abadi, H; Borgmann, V; Friedrichs, R; Nagel, R | 1 |
Benson, MC; Seaman, EK; Slawin, KM | 1 |
Bayraktar, Y; Demirel, A; Gül, O; Gündoğdu, C; Ozbilge, M; Polat, O | 1 |
Bonichon, F; Coindre, JM; de Mascarel, I; Durand, M; MacGrogan, G; Mauriac, L; Trojani, M | 1 |
Kayembe, L; Ngoy, D | 1 |
Malmström, P | 1 |
Melekos, MD; Moutzouris, GD | 1 |
Duque, JL; Loughlin, KR | 1 |
Baselli, EC; Greenberg, RE | 1 |
Han, W; Hao, J; Li, S; Li, X; Liu, S; Wang, H; Yang, D; Zhang, H | 1 |
Estes, L; Kelner, MJ; McMorris, TC; Rojas, RJ; Trani, NA | 1 |
KUNI, A; ONO, S; YAMADA, H | 1 |
REEVE, TS | 1 |
FUJII, M; HANO, S; ISHII, H; IWATA, S; KAGEYAMA, T; KURISU, T; TSUTSUMI, T; WADA, M; WAKABAYASHI, A | 1 |
GOLDENBERG, DM | 1 |
SAMPEY, JR | 1 |
IMANAGA, H | 1 |
HANDLER, AH; SARRIS, TG; WILLS, C | 1 |
KONDO, T | 1 |
OHARA, T | 1 |
GOLOMB, FM; GUMPORT, SL; LYONS, MM; MEDREK, TJ; WALKER, DG; WRIGHT, JC | 1 |
KISHIMOTO, S; LIEBERMAN, I | 1 |
SAKURAI, Y | 1 |
ANEHA, Y; KANNO, H; KIKUCHI, K; KUNII, Y; NAGANUMA, H; NATSUME, R; SATO, T; SATO, Y; TANEICHI, T; WATANABE, R; YAMAGATA, S; YAMANAKA, M; YOSHIZUMI, M | 1 |
HANO, K; NISHINO, Y | 1 |
Hale, K; Lamm, DL; McGee, WR | 1 |
Burgués, JP; Gómez, L; Jiménez-Cruz, JF; Ozonas, M; Pontones, JL; Vera, CD | 1 |
Barlow, LJ; Benson, MC | 1 |
Ali-El-Dein, B; Babjuk, M; Birtle, A; De Nunzio, C; Gudjonsson, S; Holmang, S; Inman, BA; Kaasinen, E; N'Dow, J; Oddens, JR; Okamura, K; Oosterlinck, W; Solsona, E; Sydes, MR; Sylvester, RJ; Tatar, CA | 1 |
Boorjian, SA; Lu, DD; Raman, JD | 1 |
Blodgett, G; Castle, EP; Chang, YH; Etzioni, DA; Faraj, K; Habermann, EB; Humphreys, MR; Rose, KM; Tyson Ii, MD | 1 |
27 review(s) available for mitomycin and thiotepa
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Managing superficial bladder cancer: an overview.
Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Combined Modality Therapy; Doxorubicin; Humans; Mitomycin; Risk Factors; Thiotepa; Urinary Bladder Neoplasms | 1992 |
Intravesical chemotherapy. Treatment selection, techniques, and results.
Topics: Administration, Intravesical; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Transitional Cell; Doxorubicin; Female; Humans; Male; Mitomycin; Risk Factors; Thiotepa; Urinary Bladder Neoplasms | 1992 |
Complications of intravesical chemotherapy.
Topics: Administration, Intravesical; Antineoplastic Agents; Carcinoma, Transitional Cell; Doxorubicin; Epirubicin; Ethoglucid; Humans; Mitomycin; Mitoxantrone; Thiotepa; Urinary Bladder Neoplasms | 1992 |
Bacillus Calmette-Guérin immunotherapy. Techniques and results.
Topics: Administration, Intravesical; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Clinical Protocols; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Humans; Mitomycin; Thiotepa; Urinary Bladder Neoplasms | 1992 |
Current concepts in the management of superficial bladder cancer.
Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Combined Modality Therapy; Cystoscopy; Doxorubicin; Humans; Mitomycin; Mitomycins; Prognosis; Thiotepa; Urinary Bladder Neoplasms; Vaccines, Attenuated | 1990 |
Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Doxorubicin; Humans; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Neoplasm Seeding; Thiotepa; Urinary Bladder Neoplasms | 1989 |
Intravesical chemotherapy: how effective is it?
Topics: Administration, Intravesical; BCG Vaccine; Carcinoma, Transitional Cell; Doxorubicin; Humans; Mitomycin; Mitomycins; Thiotepa; Urinary Bladder Neoplasms | 1988 |
Introduction and overview of intravesical therapy for superficial bladder cancer.
Topics: Administration, Intravesical; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Doxorubicin; Humans; Mitomycin; Mitomycins; Thiotepa; Urinary Bladder Neoplasms | 1988 |
Intravesical therapy for bladder cancer.
Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Cystoscopy; Doxorubicin; Female; Humans; Male; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Thiotepa; Urinary Bladder Neoplasms | 1988 |
Intravesical chemotherapy in the United States. An overview.
Topics: BCG Vaccine; Bleomycin; Carcinoma in Situ; Clinical Trials as Topic; Doxorubicin; Humans; Mitomycin; Mitomycins; Thiotepa; United States; Urinary Bladder Neoplasms | 1983 |
Treatment of superficial carcinoma of the bladder.
Topics: Antineoplastic Agents; BCG Vaccine; Bleomycin; Carcinoma in Situ; Carcinoma, Transitional Cell; Combined Modality Therapy; Doxorubicin; Humans; Mitomycin; Mitomycins; Radiotherapy, High-Energy; Thiotepa; Urinary Bladder Neoplasms | 1984 |
Intravesical chemotherapy of superficial bladder cancer.
Topics: Absorption; Animals; Antineoplastic Agents; BCG Vaccine; Carcinoma in Situ; Doxorubicin; Endoscopy; Ethoglucid; Humans; Hydrogen-Ion Concentration; Mitomycin; Mitomycins; Molecular Weight; Neoplasm Recurrence, Local; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1983 |
Current topics in the pathology of bladder cancer.
Topics: Carcinoma in Situ; Carcinoma, Transitional Cell; Chromosome Aberrations; Chromosomes, Human, 1-3; Cyclophosphamide; Cytodiagnosis; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1983 |
The biology and treatment of superficial bladder cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; BCG Vaccine; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystoscopy; Doxorubicin; Ethoglucid; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Prognosis; Teniposide; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1984 |
Intravesical chemotherapy.
Topics: Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Humans; Methotrexate; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Thiotepa; Urinary Bladder Neoplasms | 1984 |
Intravesical and systemic chemotherapy in the management of superficial bladder cancer.
Topics: Administration, Topical; Aged; Antineoplastic Agents; Biopsy; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Endoscopy; Female; Humans; Male; Methotrexate; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Random Allocation; Risk; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms; Vitamins | 1984 |
BCG in perspective: advances in the treatment of superficial bladder cancer.
Topics: Administration, Intravesical; BCG Vaccine; Doxorubicin; Humans; Mitomycin; Neoplasm Recurrence, Local; Prognosis; Thiotepa; Urinary Bladder Neoplasms | 1995 |
Treatment options for upper tract transitional-cell carcinoma.
Topics: Administration, Topical; BCG Vaccine; Carcinoma, Transitional Cell; Combined Modality Therapy; Humans; Kidney Neoplasms; Mitomycin; Nephrectomy; Thiotepa; Ureteral Neoplasms | 1993 |
Improved patient outcomes with BCG immunotherapy vs. chemotherapy - Swedish and worldwide experience.
Topics: Administration, Intravesical; Antibiotics, Antineoplastic; BCG Vaccine; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxorubicin; Epirubicin; Humans; Mitomycin; Sweden; Thiotepa; Treatment Outcome; Urinary Bladder Neoplasms | 2000 |
Intravesical therapy of superficial bladder cancer.
Topics: Administration, Intravesical; Antineoplastic Agents; Doxorubicin; Epirubicin; Humans; Immunotherapy; Interferons; Mitomycin; Mitoxantrone; Mycobacterium bovis; Thiotepa; Urinary Bladder Neoplasms | 2000 |
An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy.
Topics: Administration, Intravesical; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Epirubicin; Ethoglucid; Humans; Immunotherapy; Mitomycin; Thiotepa; Urinary Bladder Neoplasms | 2000 |
Intravesical therapy for superficial bladder cancer.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Antibiotics, Antineoplastic; Anticarcinogenic Agents; Antineoplastic Agents; Carcinoma, Transitional Cell; Doxorubicin; Epirubicin; Humans; Interferons; Mitomycin; Mycobacterium bovis; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents; Thiotepa; Urinary Bladder Neoplasms | 2000 |
NEW AND OLD DRUGS IN THE MANAGEMENT OF HODGKIN'S DISEASE.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anti-Bacterial Agents; Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Dexamethasone; Folic Acid Antagonists; Hodgkin Disease; Humans; Isoniazid; Mannomustine; Melphalan; Methotrexate; Mitomycin; Mitomycins; Nitrogen Mustard Compounds; Phenylbutazone; Prednisolone; Prednisone; Thiotepa | 1964 |
Bladder cancer: current optimal intravesical treatment.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Cystectomy; Doxorubicin; Drug Administration Schedule; Epirubicin; Humans; Interferon-alpha; Mitomycin; Neoplasm Recurrence, Local; Nurse's Role; Patient Selection; Risk Factors; Salvage Therapy; Survival Rate; Thiotepa; Treatment Failure; United States; Urinary Bladder Neoplasms | 2005 |
Experience with newer intravesical chemotherapy for high-risk non-muscle-invasive bladder cancer.
Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Doxorubicin; Gemcitabine; Humans; Mitomycin; Paclitaxel; Taxoids; Thiotepa; Treatment Failure; Urinary Bladder Neoplasms | 2013 |
Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma
Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Disease Progression; Doxorubicin; Epirubicin; Humans; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate; Thiotepa; Time Factors; Urinary Bladder Neoplasms | 2016 |
18 trial(s) available for mitomycin and thiotepa
Article | Year |
---|---|
Randomized trial of adjuvant chemotherapy for operable breast cancer comparing i.v. CMF to an epirubicin-containing regimen [see comment].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Injections, Intravenous; Methotrexate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Thiotepa; Vincristine; Vindesine | 1992 |
Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Protocols; Epirubicin; Female; Humans; Lymph Node Excision; Mastectomy; Methotrexate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Thiotepa; Vincristine; Vindesine | 1991 |
Approaches to the treatment of bladder cancer at Stanford.
Topics: Administration, Intravesical; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Papillary; Carcinoma, Transitional Cell; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Humans; Interferons; Mitomycin; Mitomycins; Thiotepa; Urinary Bladder Neoplasms | 1987 |
Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).
Topics: Administration, Intravesical; Carcinoma, Transitional Cell; Cystoscopy; Follow-Up Studies; Humans; Mitomycin; Mitomycins; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Prognosis; Statistics as Topic; Thiotepa; Time Factors; Urinary Bladder Neoplasms | 1989 |
[Chemotherapy of breast cancers. Coordinated evolution of therapeutic schemes from 1975 to 1985].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Mitomycin; Mitomycins; Thiotepa; Vincristine; Vindesine | 1986 |
A trial of prophylactic thiotepa or mitomycin C intravesical therapy in patients with recurrent or multiple superficial bladder cancers.
Topics: Carcinoma, Transitional Cell; Clinical Trials as Topic; Humans; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Prospective Studies; Random Allocation; Thiotepa; Urinary Bladder Neoplasms | 1986 |
Prophylactic treatment for superficial bladder cancer following transurethral resection.
Topics: Administration, Intravesical; Aged; Antineoplastic Agents; Carcinoma, Transitional Cell; Combined Modality Therapy; Doxorubicin; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Prospective Studies; Random Allocation; Tegafur; Thiotepa; Urinary Bladder Neoplasms | 1987 |
Intravesical thiotepa versus mitomycin C in patients with Ta, T1 and TIS transitional cell carcinoma of the bladder: a phase III prospective randomized study.
Topics: Administration, Intravesical; Carcinoma, Transitional Cell; Clinical Trials as Topic; Humans; Mitomycin; Mitomycins; Neoplasm Staging; Prospective Studies; Random Allocation; Thiotepa; Urinary Bladder Neoplasms | 1988 |
Intravesical thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Transitional Cell; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Prospective Studies; Random Allocation; Thiotepa; Time Factors; Urinary Bladder Neoplasms | 1985 |
Intravesical chemotherapy in the United States. An overview.
Topics: BCG Vaccine; Bleomycin; Carcinoma in Situ; Clinical Trials as Topic; Doxorubicin; Humans; Mitomycin; Mitomycins; Thiotepa; United States; Urinary Bladder Neoplasms | 1983 |
Bladder cancer chemotherapy studies supported by the National Bladder Cancer Project.
Topics: Adult; Aminoacridines; Amsacrine; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Papillary; Cisplatin; Clinical Trials as Topic; Drug Evaluation; Humans; Isotretinoin; Mitomycin; Mitomycins; Multi-Institutional Systems; Neoplasm Recurrence, Local; Thiotepa; Tretinoin; Urinary Bladder Neoplasms | 1983 |
Intravesical chemotherapy for superficial bladder cancer.
Topics: BCG Vaccine; Carcinoma, Transitional Cell; Clinical Trials as Topic; Doxorubicin; Ethoglucid; Follow-Up Studies; Humans; Mitomycin; Mitomycins; Thiotepa; Urinary Bladder Neoplasms | 1984 |
Intravesical chemotherapy.
Topics: Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Humans; Methotrexate; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Thiotepa; Urinary Bladder Neoplasms | 1984 |
Resume of selected studies of the National Bladder Cancer Collaborative Group A and new protocols.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Humans; Isomerism; Isotretinoin; Methotrexate; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Random Allocation; Registries; Thiotepa; Tretinoin; Urinary Bladder Neoplasms | 1984 |
Clinical trials in superficial and invasive bladder cancer.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Ethoglucid; Humans; Methotrexate; Mitomycin; Mitomycins; Thiotepa; Urinary Bladder Neoplasms | 1984 |
Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.
Topics: Adult; Aged; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Epirubicin; Female; Glutathione Transferase; Humans; Immunohistochemistry; Methotrexate; Middle Aged; Mitomycin; Neoplasm Proteins; Prognosis; Proteins; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Thiotepa; Trefoil Factor-1; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Vincristine; Vindesine | 1996 |
[A comparative study of thio-tepa and mitomycin C in the treatment of pterygium. Preliminary results].
Topics: Administration, Topical; Adult; Aged; Alkylating Agents; Conjunctiva; Cost-Benefit Analysis; Drug Costs; Evaluation Studies as Topic; Female; Follow-Up Studies; Headache; Humans; Iritis; Male; Middle Aged; Mitomycin; Nucleic Acid Synthesis Inhibitors; Prospective Studies; Pterygium; Pupil; Recurrence; Safety; Single-Blind Method; Tears; Thiotepa | 1998 |
[Prevention of postoperative recurrence of bladder cancer: a clinical study].
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; BCG Vaccine; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Female; Follow-Up Studies; Grifola; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Phytotherapy; Thiotepa; Urinary Bladder Neoplasms | 1999 |
72 other study(ies) available for mitomycin and thiotepa
Article | Year |
---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
[Nuclear anomaly test in human lymphocytes in vitro].
Topics: Adult; Antineoplastic Agents; Cell Nucleus; Dose-Response Relationship, Drug; Female; Humans; Lymphocytes; Male; Micronucleus Tests; Mitomycin; Razoxane; Thiotepa | 1992 |
[Intravesical BCG, mitomycin-C and thiotepa in the prevention of bladder tumor recurrence after operation].
Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Follow-Up Studies; Humans; Mitomycin; Neoplasm Recurrence, Local; Postoperative Period; Thiotepa; Urinary Bladder Neoplasms | 1992 |
Superficial bladder disease: case studies and therapeutic advances.
Topics: Administration, Intravesical; Adult; Aged; Antineoplastic Agents; BCG Vaccine; Carcinoma in Situ; Carcinoma, Papillary; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystectomy; Female; Humans; Male; Middle Aged; Mitomycin; Thiotepa; Urinary Bladder Neoplasms | 1992 |
Effects of photodynamic therapy in combination with intravesical drugs in a murine bladder tumor model.
Topics: Administration, Intravesical; Animals; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma, Transitional Cell; Combined Modality Therapy; Doxorubicin; Female; Mice; Mice, Inbred Strains; Mitomycin; Photochemotherapy; Random Allocation; Remission Induction; Thiotepa; Urinary Bladder Neoplasms | 1992 |
Neoadjuvant intra-arterial chemotherapy in inflammatory carcinoma of the breast.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Mammary Arteries; Middle Aged; Mitomycin; Thiotepa | 1992 |
[Experimental chemotherapy of peritoneal carcinomatosis of colonic origin in rats].
Topics: Animals; Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Disease Models, Animal; Drug Screening Assays, Antitumor; Female; Ifosfamide; Injections, Intraperitoneal; Injections, Intravenous; Male; Mitomycin; Peritoneal Neoplasms; Rats; Thiotepa | 1992 |
[Superficial bladder cancer: prophylaxis of recurrence and progression].
Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Bleomycin; Cisplatin; Doxorubicin; Humans; Mitomycin; Neoplasm Recurrence, Local; Thiotepa; Urinary Bladder Neoplasms | 1991 |
The effect of pH on the in vitro colony forming ability of transitional cell carcinoma cells treated with various chemotherapeutic agents: implications for in vivo therapy.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Transitional Cell; Doxorubicin; Humans; Hydrogen-Ion Concentration; Male; Mitomycin; Thiotepa; Tumor Cells, Cultured; Tumor Stem Cell Assay; Urinary Bladder Neoplasms | 1992 |
Intravesical chemotherapy for superficial carcinoma of the bladder.
Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Female; Humans; Male; Middle Aged; Mitomycin; Thiotepa; Urinary Bladder Neoplasms | 1991 |
Combination effect of recombinant human interleukin 1 alpha with antitumor drugs on syngeneic tumors in mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Interleukin-1; Mice; Mice, Inbred Strains; Mitomycin; Mitomycins; Neoplasms, Experimental; Recombinant Proteins; Survival Analysis; Thiotepa | 1991 |
In vitro study of the interaction of doxorubicin, thiotepa, and mitomycin-C, agents used for intravesical chemotherapy of superficial bladder cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Colorimetry; Doxorubicin; Drug Interactions; Drug Screening Assays, Antitumor; Humans; Mitomycin; Mitomycins; Thiotepa; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1991 |
The effect of intravesical instillations of thiotepa, mitomycin C, and adriamycin on normal urothelium: an experimental study in rats.
Topics: Administration, Intravesical; Animals; Antineoplastic Agents; Doxorubicin; Female; Mitomycin; Mitomycins; Rats; Rats, Inbred WF; Thiotepa; Time Factors; Urinary Bladder | 1991 |
Supercritical fluid chromatography/chemical ionization/mass spectrometry of some anticancer drugs in a thermospray ion source.
Topics: Antineoplastic Agents; Aziridines; Benzoquinones; Chromatography; Cyclophosphamide; Mass Spectrometry; Mitomycin; Mitomycins; Thiotepa | 1990 |
The induction of reciprocal translocations in mouse germ cells by chemicals and ionizing radiations. II. Combined effects of mitomycin C or thio-tepa with two doses of gamma-rays.
Topics: Animals; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Gamma Rays; Male; Mice; Mice, Inbred BALB C; Mitomycin; Mitomycins; Radiation, Ionizing; Spermatogonia; Spermatozoa; Thiotepa; Translocation, Genetic | 1990 |
Histopathological effects and recovery rate of rat bladders following intravesical instillation of thiotepa, doxorubicin and mitomycin C.
Topics: Administration, Intravesical; Animals; Antineoplastic Agents; Doxorubicin; Epithelium; Evaluation Studies as Topic; Female; Mitomycin; Mitomycins; Organ Size; Rats; Rats, Inbred Strains; Thiotepa; Urinary Bladder | 1990 |
Superficial bladder cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma, Papillary; Doxorubicin; Ethoglucid; Female; Humans; Interferons; Mitomycin; Mitomycins; Prognosis; Retinoids; Thiotepa; Urinary Bladder Neoplasms | 1985 |
Effects of interferon in combination with cytotoxic drugs on mouse bladder tumor (MBT-2) growth in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Doxorubicin; Drug Therapy, Combination; Female; Interferons; Mice; Mice, Inbred C3H; Mitomycin; Mitomycins; Thiotepa; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1988 |
Combined intracavitary and external beam irradiation for superficial transitional cell carcinoma of the bladder: an alternative to cystectomy for patients with recurrence after intravesical chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Transitional Cell; Cesium Radioisotopes; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Radiotherapy, High-Energy; Thiotepa; Time Factors; Urinary Bladder Neoplasms | 1989 |
Treatment modalities in superficial bladder cancer.
Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Doxorubicin; Humans; Mitomycin; Mitomycins; Papilloma; Thiotepa; Urinary Bladder Neoplasms | 1989 |
Conservative treatment of diffuse carcinoma in situ of the bladder with repeated courses of intravesical therapy.
Topics: Administration, Intravesical; Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma in Situ; Doxorubicin; Humans; Middle Aged; Mitomycin; Mitomycins; Remission Induction; Thiotepa; Urinary Bladder Neoplasms | 1989 |
Liquid chromatography-thermospray mass spectrometry of DNA adducts formed with mitomycin C, porfiromycin and thiotepa.
Topics: Animals; Cattle; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; DNA; Hydrolysis; Mass Spectrometry; Mitomycin; Mitomycins; Porfiromycin; Spectrophotometry, Ultraviolet; Thiotepa; Thymus Gland | 1989 |
Transitional explant reduction assay--a new in vitro testing system for intravesical chemotherapy.
Topics: Carcinoma, Transitional Cell; Cisplatin; Colony-Forming Units Assay; Doxorubicin; Drug Evaluation; Drug Resistance; Electronic Data Processing; Humans; Mitomycin; Mitomycins; Thiotepa; Time Factors; Tumor Stem Cell Assay; Urinary Bladder Neoplasms | 1986 |
Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa.
Topics: Biopsy; Carcinoma in Situ; Carcinoma, Transitional Cell; Cisplatin; Cystoscopy; Drug Evaluation; Drug Resistance; Humans; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Thiotepa; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms | 1986 |
Intravesical chemotherapy: studies on the relationship between osmolality and cytotoxicity.
Topics: Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Line; Cisplatin; Colony-Forming Units Assay; Doxorubicin; Epirubicin; Ethoglucid; Humans; In Vitro Techniques; Mitomycin; Mitomycins; Osmolar Concentration; Stereoisomerism; Thiotepa; Tumor Stem Cell Assay; Urinary Bladder Neoplasms | 1986 |
Intravesical chemotherapy. Studies on the relationship between pH and cytotoxicity.
Topics: Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Line; Cisplatin; Doxorubicin; Epirubicin; Ethoglucid; Humans; Hydrogen-Ion Concentration; Mitomycin; Mitomycins; Thiotepa; Tumor Stem Cell Assay; Urinary Bladder Neoplasms | 1986 |
Intravesical chemotherapy: in vitro studies on the relationship between dose and cytotoxicity.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Ethoglucid; Humans; Injections; Mitomycin; Mitomycins; Thiotepa; Time Factors; Tumor Stem Cell Assay; Urinary Bladder; Urinary Bladder Neoplasms | 1986 |
Distilled water versus chemotherapeutic agents for transitional bladder carcinoma.
Topics: Carcinoma, Transitional Cell; Cell Survival; Humans; In Vitro Techniques; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Thiotepa; Urinary Bladder Neoplasms; Water | 1986 |
Intravesical chemotherapy: combination with Tween 80 increases cytotoxicity in vitro.
Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Colony-Forming Units Assay; Doxorubicin; Ethoglucid; Humans; In Vitro Techniques; Mitomycin; Mitomycins; Polysorbates; Thiotepa; Urinary Bladder Neoplasms | 1987 |
Bacillus Calmette-Guerin for treatment of superficial transitional cell carcinoma of the bladder in patients who have failed thiotepa and/or mitomycin C.
Topics: Administration, Intravesical; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Female; Follow-Up Studies; Humans; Male; Mitomycin; Mitomycins; Prognosis; Thiotepa; Time Factors; Urinary Bladder Neoplasms | 1987 |
In vitro drug sensitivity studies in human transitional cell carcinoma of the bladder.
Topics: Carcinoma, Transitional Cell; Clone Cells; Colony-Forming Units Assay; Culture Techniques; Dimethyl Sulfoxide; Doxorubicin; Drug Resistance; Humans; Methods; Mitomycin; Mitomycins; Thiotepa; Tretinoin; Urinary Bladder Neoplasms | 1987 |
Selecting initial therapy for bladder cancer.
Topics: Administration, Intravesical; BCG Vaccine; Combined Modality Therapy; Cystoscopy; Doxorubicin; Humans; Mitomycin; Mitomycins; Neoplasm Invasiveness; Neoplasm Staging; Risk; Thiotepa; Urinary Bladder Neoplasms | 1987 |
Bladder wall calcification after topical mitomycin C.
Topics: Administration, Intravesical; Aged; Calcinosis; Carcinoma, Transitional Cell; Combined Modality Therapy; Humans; Male; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Thiotepa; Time Factors; Urinary Bladder; Urinary Bladder Diseases; Urinary Bladder Neoplasms | 1987 |
Mouse strain differences in the induction of micronuclei by polycyclic aromatic hydrocarbons.
Topics: Animals; Biotransformation; Bone Marrow; Cell Nucleus; Chromosome Aberrations; Cyclophosphamide; Mice; Mice, Inbred Strains; Mitomycin; Mitomycins; Mutagenicity Tests; Polycyclic Compounds; Thiotepa | 1987 |
Transitional cell carcinoma of the prostate following intravesical therapy for transitional cell carcinoma of the bladder.
Topics: Administration, Intravesical; Aged; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Invasiveness; Prognosis; Prostatic Neoplasms; Retrospective Studies; Thiotepa; Urinary Bladder Neoplasms | 1988 |
Combined thiotepa and mitomycin C instillation therapy for low-grade superficial bladder tumor.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Transitional Cell; Cystoscopy; Drug Eruptions; Follow-Up Studies; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Thiotepa; Urinary Bladder Neoplasms | 1985 |
Intravesical chemotherapy--frequency of instillation.
Topics: Antineoplastic Agents; Doxorubicin; Drug Administration Schedule; Ethoglucid; Humans; Mitomycin; Mitomycins; Thiotepa; Urinary Bladder Neoplasms | 1985 |
Intensive intravesical chemotherapy in the treatment of flat carcinoma in situ: is it safe?
Topics: Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Transitional Cell; Follow-Up Studies; Humans; Mitomycin; Mitomycins; Thiotepa; Time Factors; Urinary Bladder Neoplasms | 1985 |
Chemotherapy for bladder cancer.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Humans; Mitomycin; Mitomycins; Thiotepa; Urinary Bladder Neoplasms | 1985 |
In vitro chemosensitivity of human bladder cancer.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Survival; Cells, Cultured; Doxorubicin; Histocytochemistry; Humans; Mitomycin; Mitomycins; Staining and Labeling; Thiotepa; Urinary Bladder Neoplasms | 1983 |
[Chemosensitivity in established human bladder carcinoma and HELA cell lines in vitro].
Topics: Antineoplastic Agents; Bleomycin; Carbazilquinone; Carcinoma, Transitional Cell; Cell Division; Cell Line; Cell Survival; Cells, Cultured; Cisplatin; Doxorubicin; Drug Evaluation, Preclinical; Etoposide; HeLa Cells; Humans; Male; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Thiotepa; Urinary Bladder Neoplasms | 1983 |
[Intravesical chemotherapy for superficial bladder tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carbazilquinone; Cytarabine; Doxorubicin; Drug Administration Schedule; Female; Humans; Male; Mitomycin; Mitomycins; Tegafur; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1984 |
Potentiating effects of caffeine on teratogenicity of alkylating agents in mice.
Topics: Abnormalities, Drug-Induced; Abnormalities, Radiation-Induced; Alkylating Agents; Animals; Antibiotics, Antineoplastic; Caffeine; Chlorambucil; Cyclophosphamide; Drug Synergism; Embryo Implantation; Female; Fetal Resorption; Methylnitronitrosoguanidine; Mice; Mice, Inbred Strains; Mitomycin; Mitomycins; Pregnancy; Teratogens; Thiotepa | 1983 |
Comparison of the efficacy of intravesical Bacillus Calmette-Guérin with thiotepa, mitomycin C, poly I:C/poly-L-lysine and cis platinum in murine bladder cancer.
Topics: Administration, Topical; Animals; Antineoplastic Agents; BCG Vaccine; Cisplatin; Female; Mice; Mice, Inbred C3H; Mitomycin; Mitomycins; Neoplasm Transplantation; Poly I-C; Polylysine; Thiotepa; Urinary Bladder Neoplasms | 1984 |
[Correlation of the sister chromatid exchange level with chromosome aberrations induced by chemical mutagens in vivo].
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Aziridines; Bone Marrow; Chromosome Aberrations; Crossing Over, Genetic; Dose-Response Relationship, Drug; Mannomustine; Mice; Mice, Inbred CBA; Mitomycin; Mitomycins; Mutagens; Sister Chromatid Exchange; Thiotepa | 1983 |
Mitomycin C intravesical therapy in noninvasive bladder cancer after failure on thiotepa.
Topics: Adult; Aged; Drug Evaluation; Humans; Inflammation; Middle Aged; Mitomycin; Mitomycins; Skin Diseases; Thiotepa; Urinary Bladder Neoplasms | 1984 |
Persistence of SCE-inducing lesions after G0 exposure of human lymphocytes to differing classes of DNA-damaging chemicals.
Topics: Alkylating Agents; Cells, Cultured; Cisplatin; DNA Repair; Ethyl Methanesulfonate; Humans; Interphase; Lymphocytes; Mitomycin; Mitomycins; Sister Chromatid Exchange; Thiotepa | 1984 |
Choosing the right intravesical chemotherapeutic agent. Results of an in vitro monolayer cell culture assay.
Topics: Antibiotics, Antineoplastic; Cell Survival; Cells, Cultured; Doxorubicin; Humans; Mitomycin; Mitomycins; Thiotepa; Urinary Bladder Neoplasms | 1984 |
Chemotherapy of carcinomas of the digestive tract.
Topics: Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Esophageal Neoplasms; Fluorouracil; Humans; Lomustine; Mitomycin; Mitomycins; Rectal Neoplasms; Stomach Neoplasms; Thiotepa | 1982 |
Single and sequential combination intravesical chemotherapy of murine bladder cancer.
Topics: Animals; Antineoplastic Agents; Cisplatin; Disease Models, Animal; Doxorubicin; Drug Therapy, Combination; FANFT; Female; Mice; Mice, Inbred C3H; Mitomycin; Mitomycins; Neoplasms, Experimental; Organ Size; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1982 |
[Chemotherapy associating mitomycin C, thiotepa and vindesine in advanced breast cancers. Study of 100 cases (author's transl)].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Thiotepa; Vinblastine; Vindesine | 1981 |
Intravesical therapy of low stage bladder carcinoma with mitomycin C: comparison of results in untreated and previously treated patients.
Topics: Adult; Aged; Carcinoma in Situ; Carcinoma, Transitional Cell; Drug Resistance; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1982 |
[Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
Topics: Antineoplastic Agents; Carcinoma in Situ; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Humans; Methotrexate; Mitomycin; Mitomycins; Teniposide; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1982 |
Effect of different local and systemic therapy upon urinary bladder cytology.
Topics: Administration, Intravesical; Aged; Carcinoma, Transitional Cell; Combined Modality Therapy; DNA, Neoplasm; Female; Humans; Male; Mitomycin; Thiotepa; Urinary Bladder Neoplasms | 1993 |
The effects of thiotepa, mitomycin C, BCG and interferon instillation on urothelium.
Topics: Administration, Intravesical; Animals; Antineoplastic Agents; BCG Vaccine; Epithelium; Interferons; Mitomycin; Rabbits; Thiotepa; Urinary Bladder | 1996 |
Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Aziridines; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mitomycin; Neoplasm Transplantation; Sesquiterpenes; Thiotepa; Transplantation, Heterologous; Tumor Cells, Cultured | 2002 |
[On the medical therapy of malignant lymphoma].
Topics: Antineoplastic Agents; Azaguanine; Cortisone; Cyclophosphamide; Humans; Lymphoma; Mercaptopurine; Mitomycin; Mitomycins; Nitrogen Mustard Compounds; Prednisolone; Thiotepa; Triethylenemelamine | 1962 |
Chemotherapy of malignant disease. I. Solid tumours.
Topics: Cyclophosphamide; Dactinomycin; Fluorouracil; Mechlorethamine; Methotrexate; Mitomycin; Mitomycins; Neoplasms; Thiotepa | 1962 |
[CLINICAL AND EXPERIMENTAL STUDIES ON CHANGES IN THE BODY FLUIDS IN CANCER].
Topics: Antineoplastic Agents; Arginine; Ascites; Aspartate Aminotransferases; Blood Chemical Analysis; Blood Proteins; Body Fluids; Cyclophosphamide; Glycoproteins; Mechlorethamine; Mitomycin; Mitomycins; Neoplasms; Neuraminic Acids; Pharmacology; Polarography; Rats; Research; Thiotepa | 1963 |
DRUGS OF CURRENT USE FOR THE TREATMENT OF CANCER AND ALLIED DISEASES.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antineoplastic Agents; Aziridines; Busulfan; Colchicine; Dactinomycin; Diethylstilbestrol; Estrogens; Fluorouracil; Gonadal Steroid Hormones; Mercaptopurine; Methotrexate; Mitomycin; Mitomycins; Neoplasms; Podophyllum; Progestins; Quinones; Thiotepa; Triethylenemelamine; Urethane; Vinblastine | 1963 |
[PREVENTION OF THE RECURRENCE OF CANCER].
Topics: Animals; Biomedical Research; Genetic Diseases, X-Linked; Hormones; Leukemia, Hairy Cell; Lymphatic Diseases; Mice; Mitomycin; Mitomycins; Mononuclear Phagocyte System; Mycobacterium bovis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Rats; Research; Severe Combined Immunodeficiency; Surgical Procedures, Operative; Thiotepa; Zymosan | 1964 |
CHEMOTHERAPY STUDIES ON PRIMARY TUMOR GRAFTS AND METASTASES IN HAMSTERS AND MICE.
Topics: Antineoplastic Agents; Cricetinae; Cyclophosphamide; Dactinomycin; Melphalan; Mice; Mitomycin; Mitomycins; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Pharmacology; Research; Sarcoma; Sarcoma, Experimental; Thiotepa | 1964 |
THE ADVERSE EFFECTS OF CANCER CHEMOTHERAPY.
Topics: Animals; Antineoplastic Agents; Azaguanine; Carcinoma, Ehrlich Tumor; Cortisone; Cyclophosphamide; Dactinomycin; Mechlorethamine; Mice; Mitomycin; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Pharmacology; Research; Sarcoma; Sarcoma, Yoshida; Thiotepa; Toxicology | 1964 |
CHEMOTHERAPY OF GASTRIC CANCER.
Topics: Humans; Mitomycin; Mitomycins; Stomach Neoplasms; Thiotepa | 1964 |
OBSERVATIONS ON THE USE OF CANCER CHEMOTHERAPEUTIC AGENTS IN PATIENTS WITH MYCOSIS FUNGOIDES.
Topics: Alkylating Agents; Anti-Bacterial Agents; Antineoplastic Agents; Carbamates; Chlorambucil; Dactinomycin; Drug Therapy; Fluorouracil; Humans; Methotrexate; Mitomycin; Mitomycins; Mycosis Fungoides; Neoplasms; Palliative Care; Skin Neoplasms; Thiotepa; Tissue Culture Techniques; Vinblastine | 1964 |
SYNTHESIS OF RNA AND PROTEIN REQUIRED FOR THE MITOSIS OF MAMMALIAN CELLS.
Topics: Cell Division; Dactinomycin; DNA; Lysine; Metabolism; Mitomycin; Mitomycins; Mitosis; Nucleosides; Phenylalanine; Proteins; Puromycin; Rabbits; Research; RNA; Thiotepa; Thymidine; Tritium | 1964 |
IN VITRO CULTURE OF YOSHIDA SARCOMA CELLS: METHODS FOR DETERMINING ACQUIRED RESISTANCE TO DRUGS.
Topics: Animals; Antineoplastic Agents; Azaguanine; Culture Media; Cyclophosphamide; Dactinomycin; Drug Tolerance; Fluorouracil; Glucosamine; Histocytochemistry; In Vitro Techniques; Mechlorethamine; Mercaptopurine; Mitomycin; Mitomycins; Neoplasm Transplantation; Neoplasms; Nitrogen Mustard Compounds; Pharmacology; Rats; Research; Sarcoma; Sarcoma, Experimental; Sarcoma, Yoshida; Thiotepa; Tissue Culture Techniques | 1964 |
[EVALUATION OF ADJUVANT POSTOPERATIVE CHEMOTHERAPY AND RADIATION THERAPY IN GASTRIC CANCER].
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Drug Therapy; Humans; Mitomycin; Mitomycins; Neoplasms; Postoperative Complications; Stomach Neoplasms; Surgical Procedures, Operative; Thiotepa | 1964 |
PHARMACOLOGICAL STUDIES ON THE METABOLISM OF MUCOPOLYSACCHARIDES IN TUMOR CELLS.
Topics: Animals; Carbohydrate Metabolism; Carcinoma, Ehrlich Tumor; Glucuronidase; Glycosaminoglycans; Hexosamines; Hyaluronoglucosaminidase; Injections, Intraperitoneal; Mercaptopurine; Mice; Mitomycin; Mitomycins; Pharmacology; Research; Thiotepa | 1965 |
A chemosensitivity test for superficial bladder cancer based on three-dimensional culture of tumour spheroids.
Topics: Antineoplastic Agents; Ciprofloxacin; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Epirubicin; Humans; Mitomycin; Spheroids, Cellular; Thiotepa; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Verapamil | 2007 |
Intravesical chemotherapy use after radical nephroureterectomy: A national survey of urologic oncologists.
Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Doxorubicin; Epirubicin; Humans; Instillation, Drug; Kidney Neoplasms; Mitomycin; Neoplasm Recurrence, Local; Nephroureterectomy; Oncologists; Perioperative Care; Retrospective Studies; Surveys and Questionnaires; Thiotepa; Ureteral Neoplasms; Urinary Bladder Neoplasms | 2017 |
Single-dose perioperative mitomycin-C versus thiotepa for low-grade noninvasive bladder cancer.
Topics: Administration, Intravesical; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Carcinoma, Transitional Cell; Cystoscopy; Disease-Free Survival; Female; Humans; Male; Mitomycin; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Perioperative Period; Retrospective Studies; Thiotepa; Urinary Bladder Neoplasms | 2019 |